Gainers
• Chimerix, Inc. CMRX shares increased by 38.41% to $2.09 during Wednesday's pre-market session.
• Accuray, Inc. ARAY shares increased by 25% to $2.60.
• Marker Therapeutics, Inc. MRKR shares moved upwards by 15.66% to $2.29.
• TherapeuticsMD, Inc. TXMD stock rose 13.28% to $1.12. The most recent rating by Stifel, on Apr 16, is at Buy, with a price target of $15.
• Proteostasis Therapeutics, Inc. PTI stock increased by 12.84% to $1.89.
• DBV Technologies, Inc. DBVT shares increased by 10.99% to $6.97. The most recent rating by Citigroup, on Apr 6, is at Buy, with a price target of $10.
• Dare Bioscience, Inc. DARE shares moved upwards by 8.84% to $1.17. The most recent rating by Brookline Capital, on Apr 28, is at Buy, with a price target of $8.
• Millendo Therapeutics, Inc. MLND stock rose 8.28% to $1.70. The most recent rating by Oppenheimer, on Apr 7, is at Perform, with a price target of $2.
• RTI Surgical Hldgs, Inc. RTIX shares increased by 8.11% to $3.20.
• Inovio Pharmaceuticals, Inc. INO shares increased by 7.78% to $14.82. The most recent rating by HC Wainwright & Co., on Apr 29, is at Buy, with a price target of $17.
Losers
• Diffusion Pharmaceuticals, Inc. DFFN shares decreased by 9.14% to $0.47 during Wednesday's pre-market session.
• Avinger, Inc. AVGR stock declined 6.20% to $0.27. The most recent rating by Aegis Capital, on Mar 9, is at Buy, with a price target of $2.
• Medigus, Inc. MDGS stock decreased by 6.11% to $2.15.
• Second Sight Medical, Inc. EYES shares decreased by 5.91% to $1.75.
• TrovaGene, Inc. TROV shares fell 3.60% to $1.07.
• Biocept, Inc. BIOC shares declined 3.33% to $0.39.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.